Accessing VYNDAQEL

We can conduct a benefits verification to determine your patient’s health insurance coverage, including out-of-pocket costs and coverage requirements for VYNDAQEL. Additional support may be available for eligible patients during the approval process. The Interim Care program may provide new, eligible patients with up to 60 days of free VYNDAQEL shipped directly to patients if a delay of 5 or more business days from our receipt of your patient's prescription occurs during the PA or appeals process.*

Download The Enrollment Form

Prior Authorization Information

The VyndaLink team can research your patient’s health plan for prior authorization (PA) requirements and forms.

Download PA Best Practices

Appeals Information

If your patient’s claim is denied, we can provide appeals information by supplying the necessary forms, phone numbers, and contact information to assist patients who would like to appeal a PA denial.

Download sample letter of medical necessity

Specialty Pharmacy Coordination

To help support patient access, we can identify Specialty Pharmacy options based on patient coverage. VYNDAQEL is available through multiple Specialty Pharmacies in our defined distribution network.

View Specialty Pharmacy List

Financial Assistance And Additional Support During Treatment

We can help your patients understand their insurance benefits and connect them with financial assistance resources for which they may be eligible. In addition, our dedicated Patient Support Navigators provide personalized assistance and can connect patients to third-party resources.^†

Other Patient Support Offerings

Field Reimbursement Support

For additional support to help patients access their medication, Pfizer Field Reimbursement Managers are very familiar with access and reimbursement requirements for VYNDAQEL. They are available to speak with you in person at your office or over the phone. Call us at 1-888-222-8475 or let your Pfizer Account Specialist know if you’d like to get in touch with a Field Reimbursement Manager in your area.

^*Eligible patients must be new to VYNDAQEL therapy and in an active prior authorization or appeal status. Patients may be eligible for a 30-day supply of VYNDAQEL but must meet all eligibility requirements, including submission requirements and be awaiting a final coverage determination to be eligible to receive an additional 30-day supply. Interim Care is a once-in-a-lifetime offer. Terms and conditions apply.

^†Some offerings are provided through third-party organizations that operate independently and are not controlled by Pfizer. Availability of offerings and eligibility requirements are determined solely by these organizations. Patients are required to opt in for this offering.